Unveiling the Therapeutic Potential of Suyin Detoxification Prescription in Diabetic Nephropathy: A Comprehensive Study Integrating Clinical Efficacy, Network Pharmacology, and Molecular Mechanisms
Open Access
- 1 January 2025
- journal article
- Published by Wiley in Journal of Diabetes Research
- Vol. 2025 (1)
Abstract
Background: Diabetic nephropathy (DN) is a severe complication of diabetes, characterized by progressive renal dysfunction and proteinuria. Suyin Detoxification Prescription (SDP), a traditional Chinese medicine (TCM) formulation, has shown promising clinical efficacy in alleviating DN symptoms. This study is aimed at comprehensively evaluating the therapeutic effects of SDP through clinical observations, network pharmacology analysis, and molecular mechanism exploration. Methods: This study employed a randomized controlled trial combined with network pharmacology, pathological analysis, immunofluorescence, and Western blot to comprehensively investigate the therapeutic efficacy and mechanisms of SDP in DN treatment. Results: Clinical data revealed that SDP significantly reduces serum creatinine levels ( p = 0.009) and reduced proteinuria ( p = 0.03) in DN patients. Network pharmacology successfully established an interaction network among active components of SDP, FXR targets, and DN pathological processes. Experimental validation demonstrated that the formula significantly downregulated TNF‐ α , gp91, and P‐MLK1 expression in renal tissues of diabetic mice. Notably, FXR knockout markedly attenuated the renal protective effects of SDP in DN mice. Conclusion: SDP exerts renal protective effects in DN through FXR activation, mitigating oxidative stress and inflammatory damage, while reducing proteinuria and renal function impairment, providing novel therapeutic strategies for DN management.Keywords
Funding Information
- National Natural Science Foundation of China (82474427)
This publication has 29 references indexed in Scilit:
- Suyin Detoxification Prescription Regulates the Klotho and ERK/NF-κB Signaling Pathways to Alleviate Renal InjuryCell Biochemistry and Biophysics, 2025
- β-Sitosterol Mitigates Apoptosis, Oxidative Stress and Inflammatory Response by Inactivating TLR4/NF-кB Pathway in Cell Models of Diabetic NephropathyCell Biochemistry and Biophysics, 2024
- The mechanisms underlying Chinese medicines to treat inflammation in diabetic kidney diseaseJournal of Ethnopharmacology, 2024
- FTZ polysaccharides ameliorate kidney injury in diabetic mice by regulating gut-kidney axisPhytomedicine, 2023
- Network pharmacology-based study on the mechanism of ShenKang injection in diabetic kidney disease through Keap1/Nrf2/Ho-1 signaling pathwayPhytomedicine, 2023
- Diabetic Kidney DiseaseMedical Clinics of North America, 2023
- The mechanisms of Qizhu Tangshen formula in the treatment of diabetic kidney disease: Network pharmacology, machine learning, molecular docking and experimental assessmentPhytomedicine, 2022
- Evaluation of VEGF mediated pro-angiogenic and hemostatic effects and chemical marker investigation for Typhae Pollen and its processed productJournal of Ethnopharmacology, 2021
- Shenyan Kangfu tablet alleviates diabetic kidney disease through attenuating inflammation and modulating the gut microbiotaJournal of Natural Medicines, 2020
- Scoparone attenuates high glucose-induced extracellular matrix accumulation in rat mesangial cellsEuropean Journal of Pharmacology, 2017